Want to see RMD full AI Analyst Report?
Total Valuation
Resmed has a market cap or net worth of $30.74B. The enterprise value is $27.61K.
Market Cap$30.74B
Enterprise Value$27.61K
Share Statistics
Resmed has 145,056,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding145,056,380
Owned by Insiders0.51%
Owned by Institutions3.19%
Financial Efficiency
Resmed’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 19.05%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)19.05%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee533.34K
Profits Per Employee143.71K
Employee Count10,600
Asset Turnover0.63
Inventory Turnover2.33
Valuation Ratios
The current PE Ratio of Resmed is 20.8. Resmed’s PEG ratio is 0.00.
PE Ratio20.8
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow9.83
PEG Ratio0.00
Income Statement
In the last 12 months, Resmed had revenue of 5.65B and earned 1.52B in profits. Earnings per share was 10.47.
Revenue5.65B
Gross Profit3.45B
Operating Income1.92B
Pretax Income1.92B
Net Income1.52B
EBITDA2.16B
Earnings Per Share (EPS)10.47
Cash Flow
In the last 12 months, operating cash flow was 3.16B and capital expenditures -267.46M, giving a free cash flow of 2.89B billion.
Operating Cash Flow3.16B
Free Cash Flow2.89B
Free Cash Flow per Share19.92
Dividends & Yields
Resmed pays an annual dividend of $0.66, resulting in a dividend yield of 1.13%
Dividend Per Share$0.66
Dividend Yield1.13%
Payout Ratio22.28%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change-24.73%
50-Day Moving Average200.35
200-Day Moving Average229.97
Relative Strength Index (RSI)53.75
Average Volume (3m)1.50M
Important Dates
Resmed upcoming earnings date is Oct 22, 2026, After Close (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateOct 22, 2026
Ex-Dividend Date―
Financial Position
Resmed as a current ratio of 3.10, with Debt / Equity ratio of 12.54%
Current Ratio3.10
Quick Ratio2.42
Debt to Market Cap0.00
Net Debt to EBITDA-0.34
Interest Coverage Ratio37.80
Taxes
In the past 12 months, Resmed has paid 396.12M in taxes.
Income Tax396.12M
Effective Tax Rate0.21
Enterprise Valuation
Resmed EV to EBITDA ratio is -0.34, with an EV/FCF ratio of -0.39.
EV to Sales-0.11
EV to EBITDA-0.34
EV to Free Cash Flow-0.39
EV to Operating Cash Flow-0.36
Balance Sheet
Resmed has $1.47B in cash and marketable securities with $825.92M in debt, giving a net cash position of $643.32M billion.
Cash & Marketable Securities$1.47B
Total Debt$825.92M
Net Cash$643.32M
Net Cash Per Share$4.43
Tangible Book Value Per Share$0.00
Margins
Gross margin is 61.06%, with operating margin of 33.37%, and net profit margin of 26.94%.
Gross Margin61.06%
Operating Margin33.37%
Pretax Margin33.95%
Net Profit Margin26.94%
EBITDA Margin33.37%
EBIT Margin0.00%
Analyst Forecast
The average price target for Resmed is $237.91, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$237.91
Price Target Upside21.84% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast9.85%
EPS Growth Forecast9.65%